Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

Kelsie L. Thu, Emily A. Vucic, Raj Chari, Wei Zhang, William W. Lockwood, John C. English, Rong Fu, Pei Wang, Ziding Feng, Calum E. MacAulay, Adi F. Gazdar, Stephen Lam, Wan L. Lam

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Recent evidence suggests that the observed clinical distinctions between lung tumors in smokers and never smokers (NS) extend beyond specific gene mutations, such as EGFR, EML4-ALK, and KRAS, some of which have been translated into targeted therapies. However, the molecular alterations identified thus far cannot explain all of the clinical and biological disparities observed in lung tumors of NS and smokers. To this end, we performed an unbiased genome-wide, comparative study to identify novel genomic aberrations that differ between smokers and NS. High resolution whole genome DNA copy number profiling of 69 lung adenocarcinomas from smokers (n = 39) and NS (n = 30) revealed both global and regional disparities in the tumor genomes of these two groups. We found that NS lung tumors had a greater proportion of their genomes altered than those of smokers. Moreover, copy number gains on chromosomes 5q, 7p, and 16p occurred more frequently in NS. We validated our findings in two independently generated public datasets. Our findings provide a novel line of evidence distinguishing genetic differences between smoker and NS lung tumors, namely, that the extent of segmental genomic alterations is greater in NS tumors. Collectively, our findings provide evidence that these lung tumors are globally and genetically different, which implies they are likely driven by distinct molecular mechanisms.

Original languageEnglish (US)
Article numbere33003
JournalPLoS One
Volume7
Issue number3
DOIs
StatePublished - Mar 7 2012

Fingerprint

Genomic Instability
lung neoplasms
Ports and harbors
adenocarcinoma
Tumors
lungs
genomics
Genes
genome
Lung
Neoplasms
Genome
neoplasms
Chromosomes
Adenocarcinoma of lung
Aberrations
chromosomes
mutation
therapeutics
DNA

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability. / Thu, Kelsie L.; Vucic, Emily A.; Chari, Raj; Zhang, Wei; Lockwood, William W.; English, John C.; Fu, Rong; Wang, Pei; Feng, Ziding; MacAulay, Calum E.; Gazdar, Adi F.; Lam, Stephen; Lam, Wan L.

In: PLoS One, Vol. 7, No. 3, e33003, 07.03.2012.

Research output: Contribution to journalArticle

Thu, KL, Vucic, EA, Chari, R, Zhang, W, Lockwood, WW, English, JC, Fu, R, Wang, P, Feng, Z, MacAulay, CE, Gazdar, AF, Lam, S & Lam, WL 2012, 'Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability', PLoS One, vol. 7, no. 3, e33003. https://doi.org/10.1371/journal.pone.0033003
Thu, Kelsie L. ; Vucic, Emily A. ; Chari, Raj ; Zhang, Wei ; Lockwood, William W. ; English, John C. ; Fu, Rong ; Wang, Pei ; Feng, Ziding ; MacAulay, Calum E. ; Gazdar, Adi F. ; Lam, Stephen ; Lam, Wan L. / Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability. In: PLoS One. 2012 ; Vol. 7, No. 3.
@article{e85a0683ba794cf5ab0468fe6159daca,
title = "Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability",
abstract = "Recent evidence suggests that the observed clinical distinctions between lung tumors in smokers and never smokers (NS) extend beyond specific gene mutations, such as EGFR, EML4-ALK, and KRAS, some of which have been translated into targeted therapies. However, the molecular alterations identified thus far cannot explain all of the clinical and biological disparities observed in lung tumors of NS and smokers. To this end, we performed an unbiased genome-wide, comparative study to identify novel genomic aberrations that differ between smokers and NS. High resolution whole genome DNA copy number profiling of 69 lung adenocarcinomas from smokers (n = 39) and NS (n = 30) revealed both global and regional disparities in the tumor genomes of these two groups. We found that NS lung tumors had a greater proportion of their genomes altered than those of smokers. Moreover, copy number gains on chromosomes 5q, 7p, and 16p occurred more frequently in NS. We validated our findings in two independently generated public datasets. Our findings provide a novel line of evidence distinguishing genetic differences between smoker and NS lung tumors, namely, that the extent of segmental genomic alterations is greater in NS tumors. Collectively, our findings provide evidence that these lung tumors are globally and genetically different, which implies they are likely driven by distinct molecular mechanisms.",
author = "Thu, {Kelsie L.} and Vucic, {Emily A.} and Raj Chari and Wei Zhang and Lockwood, {William W.} and English, {John C.} and Rong Fu and Pei Wang and Ziding Feng and MacAulay, {Calum E.} and Gazdar, {Adi F.} and Stephen Lam and Lam, {Wan L.}",
year = "2012",
month = "3",
day = "7",
doi = "10.1371/journal.pone.0033003",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability

AU - Thu, Kelsie L.

AU - Vucic, Emily A.

AU - Chari, Raj

AU - Zhang, Wei

AU - Lockwood, William W.

AU - English, John C.

AU - Fu, Rong

AU - Wang, Pei

AU - Feng, Ziding

AU - MacAulay, Calum E.

AU - Gazdar, Adi F.

AU - Lam, Stephen

AU - Lam, Wan L.

PY - 2012/3/7

Y1 - 2012/3/7

N2 - Recent evidence suggests that the observed clinical distinctions between lung tumors in smokers and never smokers (NS) extend beyond specific gene mutations, such as EGFR, EML4-ALK, and KRAS, some of which have been translated into targeted therapies. However, the molecular alterations identified thus far cannot explain all of the clinical and biological disparities observed in lung tumors of NS and smokers. To this end, we performed an unbiased genome-wide, comparative study to identify novel genomic aberrations that differ between smokers and NS. High resolution whole genome DNA copy number profiling of 69 lung adenocarcinomas from smokers (n = 39) and NS (n = 30) revealed both global and regional disparities in the tumor genomes of these two groups. We found that NS lung tumors had a greater proportion of their genomes altered than those of smokers. Moreover, copy number gains on chromosomes 5q, 7p, and 16p occurred more frequently in NS. We validated our findings in two independently generated public datasets. Our findings provide a novel line of evidence distinguishing genetic differences between smoker and NS lung tumors, namely, that the extent of segmental genomic alterations is greater in NS tumors. Collectively, our findings provide evidence that these lung tumors are globally and genetically different, which implies they are likely driven by distinct molecular mechanisms.

AB - Recent evidence suggests that the observed clinical distinctions between lung tumors in smokers and never smokers (NS) extend beyond specific gene mutations, such as EGFR, EML4-ALK, and KRAS, some of which have been translated into targeted therapies. However, the molecular alterations identified thus far cannot explain all of the clinical and biological disparities observed in lung tumors of NS and smokers. To this end, we performed an unbiased genome-wide, comparative study to identify novel genomic aberrations that differ between smokers and NS. High resolution whole genome DNA copy number profiling of 69 lung adenocarcinomas from smokers (n = 39) and NS (n = 30) revealed both global and regional disparities in the tumor genomes of these two groups. We found that NS lung tumors had a greater proportion of their genomes altered than those of smokers. Moreover, copy number gains on chromosomes 5q, 7p, and 16p occurred more frequently in NS. We validated our findings in two independently generated public datasets. Our findings provide a novel line of evidence distinguishing genetic differences between smoker and NS lung tumors, namely, that the extent of segmental genomic alterations is greater in NS tumors. Collectively, our findings provide evidence that these lung tumors are globally and genetically different, which implies they are likely driven by distinct molecular mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=84863273943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863273943&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0033003

DO - 10.1371/journal.pone.0033003

M3 - Article

C2 - 22412972

AN - SCOPUS:84863273943

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e33003

ER -